Antimalarial mass drug administration: ethical considerations

Phaik Yeong Cheah and Nicholas J White
Int Health 2016; 8: 235–238

4 pp. 140 kB
http://m.inthealth.oxfordjournals.org/content/8/4/235.full.pdf4.cover

Falciparum malaria is a major cause of death and illness in tropical countries, particularly in childhood. In endemic countries, a significant proportion of the community is infected with malaria asymptomatically. One promising way to eliminate malaria is to give the entire population malaria treatment. This is called mass drug administration (MDA) and it raises a number of ethical issues, as possible long-term benefits are uncertain. The drawbacks of MDA are: inconvenience, potential toxicity, loss of confidence in the elimination campaign, possible drug resistance (though highly unlikely), and the potential for a rebound of malaria illness (if immunity is lost and malaria is reintroduced later).

(Visited 21 times, 1 visits today)
This entry was posted in Essential Medicines, General, Malaria. Bookmark the permalink.